Psychology

Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan

Carbonaro, T. M., Johnson, M. W., & Griffiths, R. R | Psychopharmacology | 5 June 2020

Psilocybin: from ancient magic to modern medicine

Nichols, D. E. | The Journal of Antibiotics | 12 May 2020

Long-term Follow-Up Outcomes of MDMA-assisted Psychotherapy for Treatment of PTSD: A Longitudinal Pooled Analysis of Six Phase 2 Trials

Jerome, L., Feduccia, A. A., Wang, J. B., Hamilton, S., Yazar-Klosinski, B., Emerson, A., ... & Doblin, R. | Psychopharmacology | 11 May 2020

Can Psychedelics Alleviate Symptoms of Cluster Headache and Accompanying Mental Health Problems? A Case Report Involving Hawaiian Baby Woodrose

Johnson, S., & Black, Q. C. | Journal of Psychoactive Drugs | 7 May 2020

Psilocybin and LSD Have No Long-Lasting Effects in an Animal Model of Alcohol Relapse

Meinhardt, M. W., Güngör, C., Skorodumov, I., Mertens, L. J., & Spanagel, R. | Neuropsychopharmacology | 5 May 2020

Chronic pain and psychedelics: a review and proposed mechanism of action

Castellanos, J. P., Woolley, C., Bruno, K. A., Zeidan, F., Halberstadt, A., & Furnish, T. | Regional Anesthesia & Pain Medicine | 4 May 2020

The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being – An Early Review

Bornemann, J. | Journal of Psychoactive Drugs | 2 May 2020

Psychedelics and Psychedelic-Assisted Psychotherapy

Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I. | American Journal of Psychiatry | 1 May 2020

A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats

Rodríguez, P., Urbanavicius, J., Prieto, J. P., Fabius, S., Reyes, A. L., Havel, V., ... & Carrera, I. | ACS Chemical Neuroscience | 24 April 2020

Registered Clinical Trials Investigating Ketamine for Psychiatric Disorders

Peyrovian, B., McIntyre, R., Phan, L., Lui, L. M., Gill, H., Majeed, A., ... & Rosenblat, J. D. | Journal of Psychiatric Research | 9 April 2020

Psychedelic Psychiatry’s Brave New World

Nutt, D., Erritzoe, D., & Carhart-Harris, R. | Cell | 2 April 2020

Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review

Heuschkel, K., & Kuypers, K. P. | Frontiers in Psychiatry | 31 March 2020

Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.

O’Callaghan, C., Hubik, D. J., Dwyer, J., Williams, M., & Ross, M. | Journal of Music Therapy | 30 March 2020

Long-term effects of psychedelic drugs: A systematic review

Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C., & Davis, A. K. | Neuroscience & Biobehavioral Reviews | 15 March 2020

Reviewing the Potential of Psychedelics for the Treatment of PTSD.

Krediet, E., Bostoen, T., Breeksema, J., van Schagen, A., Passie, T., & Vermetten, E. | International Journal of Neuropsychopharmacology | 14 March 2020

The Psychedelic Renaissance and Its Forensic Implications

Holoyda, B. | The journal of the American Academy of Psychiatry and the Law | 09 Mar 2020

Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects.

Lancelotta, R. L., & Davis, A. K. | Journal of Psychoactive Drugs | 09 Mar 2020